Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07201194

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Vejle Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone. A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone. The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment

Conditions

Interventions

TypeNameDescription
OTHERHolistic acupuncture and acupressureThe intervention consists of one holistic and individualized consultation with an oncologist trained in acupuncture, in connection with outpatient chemotherapy. The consultation follows the principles of Traditional Chinese Medicine (TCM). The theoretical framework applied is Zang-Fu, which describes organ imbalances and aligns closely with Western medical understanding. Based on individual assessment and anamnesis, the patient receives acupuncture combined with acupressure. A maximum of 10 needles will be used, regardless of whether a deficiency or excess condition is identified. The acupuncture needles used are CAIR Super Silicon CSC-1, size 0.20 × 25 mm. The needles are inserted perpendicularly, except for Yin Tang, which is inserted transversely. The needles will remain in place for 25 minutes.
OTHERStandard medical treatmentStandard treatment and care includes chemotherapy, supportive antiemetic medication, close monitoring, and management of the patient's symptoms, side effects, and overall health.

Timeline

Start date
2025-11-17
Primary completion
2026-04-01
Completion
2026-12-31
First posted
2025-10-01
Last updated
2025-12-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07201194. Inclusion in this directory is not an endorsement.